← Back to directory
C
ClavystBio
SingaporeWebsite ↗
ClavystBio is a life sciences investor and venture builder established by Temasek, focused on accelerating the commercialization of breakthrough ideas into health impact. The firm invests in and partners with founders and entrepreneurs to launch and grow global life sciences companies from Singapore.
Last raised
Unknown
Latest fund size
$650M
Latest Reported Fund
AUM
$4.2B
estimated
Funds raised
Capital this firm has raised, newest first
Latest Reported Fund
Unknown
$650M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Biobot SurgicalLead | — | $15.5M | Jun 2026 | clavystbio.com ↗ |
| Leyden Labs | — | $43.2M | Jun 2026 | clavystbio.com ↗ |
| Rejoni, Inc. | — | $25M | Jun 2026 | clavystbio.com ↗ |
| RespireeLead | Series A | $11.6M | Dec 2025 | firstwordpharma.com ↗ |
| Allay TherapeuticsLead | — | $57.5M | Jun 2025 | techinasia.com ↗ |
Sources
Where this data came from